Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Jun 30, 2022 8-K
UPLOAD Jun 30, 2022
CORRESP Jun 29, 2022
UPLOAD Jun 23, 2022
DEFA14A Jun 16, 2022 DEFA14A
SC 13G Jun 9, 2022 SC 13G
8-K May 26, 2022 8-K
10-Q May 16, 2022 10-Q
8-K May 16, 2022 8-K
8-K May 2, 2022 8-K
424B5 May 2, 2022 424B5
EFFECT Apr 29, 2022
DEF 14A Apr 29, 2022 DEF 14A
CORRESP Apr 27, 2022
UPLOAD Apr 25, 2022
S-3 Apr 20, 2022 FORM S-3
PRE 14A Apr 14, 2022 PRE 14A
4 Apr 13, 2022 OWNERSHIP DOCUMENT
8-K Apr 4, 2022 8-K
10-K Mar 31, 2022 10-K
8-K Mar 31, 2022 8-K
4 Feb 28, 2022 OWNERSHIP DOCUMENT
4 Feb 28, 2022 OWNERSHIP DOCUMENT
8-K Feb 24, 2022 8-K
SC 13G/A Feb 14, 2022 PROTALIX BIOTHERAPEUTICS, INC.
← Newer Page 7 of 38 · 935 filings Older →